Azilsartan Medoxomil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 120 publications

Antihypertensive Efficacy and Safety of Angiotensin Receptor Blockers (ARBs) with and without Inverse Agonism: A Systematic Review and Network Meta-analysis.

Antihypertensive Efficacy and Safety of Angiotensin Receptor Blockers (ARBs) with and without Inverse Agonism: A Systematic Review and Network Meta-analysis.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions

Published: March 09, 2026

Repurposing Azilsartan medoxomil attenuates periodontitis by targeting SERPINB9 to promote apoptosis of IL1B+ macrophages.

Repurposing Azilsartan medoxomil attenuates periodontitis by targeting SERPINB9 to promote apoptosis of IL1B+ macrophages.

Journal: International immunopharmacology

Published: February 07, 2026

Azilsartan prevents central modulation of BDNF and PPARγ in Alzheimer's pathology through amyloidogenic and inflammatory pathways: experimental and computational evidence.

Azilsartan prevents central modulation of BDNF and PPARγ in Alzheimer's pathology through amyloidogenic and inflammatory pathways: experimental and computational evidence.

Journal: Inflammopharmacology

Published: November 28, 2025

FDA Drug Repurposing Uncovers Modulators of Dopamine D2 Receptor Localization via Disruption of the NCS-1 Interaction.

FDA Drug Repurposing Uncovers Modulators of Dopamine D2 Receptor Localization via Disruption of the NCS-1 Interaction.

Journal: Journal of medicinal chemistry

Published: November 10, 2025

Green and white analytical chemistry: Advances, comparisons, future perspectives, and a proposal for green financing model for analytical chemistry.

Green and white analytical chemistry: Advances, comparisons, future perspectives, and a proposal for green financing model for analytical chemistry.

Journal: Journal of pharmaceutical sciences

Published: August 19, 2025

Authors' Reply: Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study.

Authors' Reply: Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study.

Journal: Epidemiology and health

Published: August 18, 2025

Letter to the Editor: Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study.

Letter to the Editor: Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study.

Journal: Epidemiology and health

Published: August 12, 2025

A Phase III Randomized Controlled Trial Evaluating the Efficacy and Safety of Azilsartan Medoxomil and Amlodipine Combination Therapy in Patients With Mild-to-Moderate Essential Hypertension Inadequately Controlled on Monotherapy.

A Phase III Randomized Controlled Trial Evaluating the Efficacy and Safety of Azilsartan Medoxomil and Amlodipine Combination Therapy in Patients With Mild-to-Moderate Essential Hypertension Inadequately Controlled on Monotherapy.

Journal: Clinical therapeutics

Published: June 16, 2025

Bioanalytical Method Development and Validation of Dapagliflozin in Human Plasma Using RP-HPLC Method.

Bioanalytical Method Development and Validation of Dapagliflozin in Human Plasma Using RP-HPLC Method.

Journal: Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology

Published: June 08, 2025

Mechanistic insights into a thermoresponsive in situ nanoemulgel of azilsartan medoxomil for intranasal delivery: a promising nanotherapeutic approach to target dementia.

Mechanistic insights into a thermoresponsive in situ nanoemulgel of azilsartan medoxomil for intranasal delivery: a promising nanotherapeutic approach to target dementia.

Journal: Biomaterials science

Published: June 03, 2025

Medoxomil Prodrug Strategies.

Medoxomil Prodrug Strategies.

Journal: Journal of medicinal chemistry

Published: April 22, 2025

Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study.

Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study.

Journal: Epidemiology and health

Published: March 10, 2025

Showing 1-12 of 120

Last Updated: 09/26/2026